Form 4: Aehr Test Systems Executive VP Ray-Chaudhuri Reports Stock Purchases
SEC Form 4
Avijit K. Ray-Chaudhuri, Executive VP of R&D at Aehr Test Systems, reported purchasing shares of common stock in two transactions on July 18 and 19, 2024.
Summary
- On July 18, 2024, Avijit K. Ray-Chaudhuri, Executive VP of R&D at Aehr Test Systems, purchased 2,450 shares of common stock at a price of $20.32 per share.
- Following this transaction, Ray-Chaudhuri directly owned 25,509 shares.
- On July 19, 2024, Ray-Chaudhuri purchased an additional 2,591 shares at $18.55 per share.
- After the second purchase, the total number of shares directly owned by Ray-Chaudhuri increased to 28,100, including unvested restricted stock units.
- The transactions were reported on a Form 4 filing with the SEC.
- Ray-Chaudhuri has granted power of attorney to Gayn Erickson, Chris Siu, and Vernon Rogers to complete and file forms related to securities transactions.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The purchase of shares by an executive is generally viewed as a positive sign, indicating confidence in the company's future. However, without additional context, the impact is limited.
Positives
- Executive VP's purchase of company stock may signal confidence in the company's future prospects.
Industry Context
Insider trading activity is closely monitored as it can provide insights into a company's performance and future prospects. Purchases by executives are often seen as a positive sign.
Stakeholder Impact
- The stock purchases could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 2024-01-04 | Date of Power of Attorney execution. |
| 2024-07-18 | Date of first stock purchase: 2,450 shares at $20.32. |
| 2024-07-19 | Date of second stock purchase: 2,591 shares at $18.55. |
| 2024-07-29 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.